Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,456,000 | 2,463,000 | 2,544,000 | 2,508,500 | 2,589,100 |
| Cost of Goods | 592,700 | 662,800 | 570,900 | 469,500 | 484,000 |
| Gross Profit | 1,863,300 | 1,800,200 | 1,973,100 | 2,039,000 | 2,105,100 |
| Operating Expenses | 1,277,100 | 1,293,300 | 1,257,100 | 724,400 | 1,264,200 |
| Operating Income | 586,900 | 507,700 | 716,900 | 1,315,100 | 840,900 |
| Other Income | 121,200 | -69,400 | -113,100 | 56,000 | 434,500 |
| Pre-tax Income | 708,100 | 438,300 | 603,800 | 1,371,100 | 1,275,400 |
| Income Tax | 114,800 | 50,700 | 54,300 | 236,200 | 216,700 |
| Net Income Continuous | 593,300 | 387,600 | 549,500 | 1,134,900 | 1,058,700 |
| Minority Interests | 1,700 | -300 | -900 | 200 | 700 |
| Net Income | $591,600 | $387,900 | $550,400 | $1,134,700 | $1,058,000 |
| EPS Basic Total Ops | 4.09 | 2.69 | 3.79 | 7.86 | 7.25 |
| EPS Basic Continuous Ops | 4.10 | 2.68 | 3.78 | 7.86 | 7.26 |
| EPS Diluted Total Ops | 4.07 | 2.67 | 3.73 | 7.84 | 7.24 |
| EPS Diluted Continuous Ops | 4.08 | 2.67 | 3.73 | 7.84 | 7.24 |
| EPS Diluted Before Non-Recurring Items | 4.02 | 3.40 | 4.05 | N/A | N/A |
| EBITDA(a) | $704,300 | $620,000 | $956,300 | $1,435,800 | $975,700 |